We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience. You can read our Cookie Policy here.

Advertisement
MRC Technology Appoints Finance Director
News

MRC Technology Appoints Finance Director

MRC Technology Appoints Finance Director
News

MRC Technology Appoints Finance Director

Read time:
 

Want a FREE PDF version of This News Story?

Complete the form below and we will email you a PDF version of "MRC Technology Appoints Finance Director"

First Name*
Last Name*
Email Address*
Country*
Company Type*
Job Function*
Would you like to receive further email communication from Technology Networks?

Technology Networks Ltd. needs the contact information you provide to us to contact you about our products and services. You may unsubscribe from these communications at any time. For information on how to unsubscribe, as well as our privacy practices and commitment to protecting your privacy, check out our Privacy Policy

MRC Technology, an independent life science medical research charity, has appointed Andrew Mercieca as its Finance Director from 1 April 2015. Andrew joined the company as Interim Finance Director in August 2014. He brings a wealth of senior international finance experience from previous roles at leading technology and pharmaceutical companies, including Syniverse Technologies, Astellas Pharma and Merck Serono.

Andrew-Mercieca.jpg
Andrew Mercieca, Finance Director at MRC Technology

Dave Tapolczay, Chief Executive Officer, MRC Technology said: “Andrew has been a great asset to the Executive Team and the business since he joined last summer. MRC Technology is increasing its global partnerships, and Andrew’s EMEA, Asia and USA experience is a valued contribution to our drive to improve health through science across the world.”

Andrew Mercieca responded, saying: “MRC Technology has an impressive track record of connecting promising research with industry to ensure it fulfils its potential and making treatments available to patients, and I am very pleased to be supporting these efforts.”
Advertisement